Laboratory‐Based Surveillance of Paratyphoid Fever in the United States: Travel and Antimicrobial Resistance
Open Access
- 1 June 2008
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 46 (11) , 1656-1663
- https://doi.org/10.1086/587894
Abstract
Background. The incidence of paratyphoid fever, including paratyphoid fever caused by antimicrobial-resistant strains, is increasing globally. HoweveKeywords
This publication has 27 references indexed in Scilit:
- Emergence of Salmonella enterica serotype Paratyphi A as a major cause of enteric fever in Kathmandu, NepalTransactions of the Royal Society of Tropical Medicine and Hygiene, 2006
- Salmonella enterica Serovar Paratyphi A and S. enterica Serovar Typhi Cause Indistinguishable Clinical Syndromes in Kathmandu, NepalClinical Infectious Diseases, 2006
- Salmonella paratyphiendocarditisActa Cardiologica, 2006
- Salmonella paratyphi osteomyelitis and psoas abscessTropical Doctor, 2006
- Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case seriesBMC Infectious Diseases, 2004
- Antimicrobial Susceptibility of 128 Salmonella enterica Serovar Typhi and Paratyphi A Isolates from Northern IndiaChemotherapy, 2004
- InvasiveSalmonellaInfections in the United States, FoodNet, 1996–1999: Incidence, Serotype Distribution, and OutcomeClinical Infectious Diseases, 2004
- Cancer mortality in chronic typhoid and paratyphoid carriersThe Lancet, 1994
- Hydrocortisone in chloramphenicol-treated severe typhoid fever in Papua New GuineaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1991
- PRELIMINARY REPORT ON THE BENEFICIAL EFFECT OF CHLOROMYCETIN IN THE TREATMENT OF TYPHOID FEVERAnnals of Internal Medicine, 1948